Does probenecid increase tigecycline’s bioavailability?
The information provided here does not include any data showing that probenecid increases tigecycline bioavailability. Without pharmacokinetic studies, labeling information, or interaction data, it’s not possible to say whether probenecid increases tigecycline exposure.
What would determine whether probenecid changes tigecycline levels?
Probenecid is commonly used to affect drug transport and excretion pathways, so the key question for tigecycline is whether tigecycline’s absorption, distribution, metabolism, or clearance relies on the same transporters that probenecid inhibits. If tigecycline is cleared via pathways sensitive to probenecid, systemic exposure might change; if not, probenecid would be unlikely to increase bioavailability.
Is there a known tigecycline–probenecid interaction from labeling or studies?
No labeling or study details are included in the provided information, so no interaction conclusion can be drawn.
What to check next (if you’re looking for an evidence-based answer)
To answer this reliably, you’d typically look for:
- Tigecycline prescribing information for drug–drug interaction statements
- Clinical pharmacokinetic studies of tigecycline with probenecid (or strong inducers/inhibitors of the same transporters)
- Published review articles or interaction databases that report changes in AUC, Cmax, and bioavailability
If you share the tigecycline label text or a citation/database link you’re using, I can interpret it and tell you whether it supports probenecid increasing tigecycline bioavailability.